Suchergebnisse - "Pinato, David J"

PubPharm (261)

1

The Hammersmith Score optimises patient selection and predicts for overall survival in early-phase cancer trial participants independent of tumour burden

enthalten in: Chemotherapy | 2024

von Korolewicz, J. | Scheiner, B. | Fulgenzi, C. | +22

2

Beyond Time and Space : Charting Dynamic Evolution of Sporadic Colorectal Cancer

enthalten in: Gastroenterology | 2024

von Lombardi, P. | Pinato, D.

3

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT) : from premalignant to metastatic disease

enthalten in: Journal for immunotherapy of cancer | 2024

von Luke, J. | Davar, D. | Andtbacka, R. | +23

4

Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma : the PETAL phase Ib study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Pinato, D. | D'Alessio, A. | Fulgenzi, C. | +21

5

Immunotherapy at all stages of hepatocellular carcinoma

enthalten in: Nature medicine | 2024

von Pinato, D. | Fulgenzi, C. | D'Alessio, A.

6

Merits and boundaries of the BCLC staging and treatment algorithm : Learning from the past to improve the future with a novel proposal

enthalten in: Journal of hepatology | 2024

von Trevisani, F. | Vitale, A. | Kudo, M. | +4

7

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer : Results of a propensity-matched analysis of the OnCovid registry

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mostaghim, A. | Minkove, S. | Aguilar-Company, J. | +43

8

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

9

Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Hedayat, S. | Cascione, L. | Cunningham, D. | +43

10

Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy

enthalten in: Gastroenterology | 2024

von D'arienzo, P. | Pinato, D.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]